Previous Close | 65.16 |
Open | 66.82 |
Bid | 65.84 x 60000 |
Ask | 66.38 x 60000 |
Day's Range | 66.82 - 66.82 |
52 Week Range | 51.50 - 86.50 |
Volume | |
Avg. Volume | 53 |
Market Cap | 9.729B |
Beta (5Y Monthly) | 1.18 |
PE Ratio (TTM) | 29.57 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.18 (0.25%) |
Ex-Dividend Date | Feb 29, 2024 |
1y Target Est | N/A |
Bruker (BRKR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Bruker Corporation (NASDAQ:BRKR) Q1 2024 Earnings Call Transcript May 2, 2024 Bruker Corporation misses on earnings expectations. Reported EPS is $0.3489 EPS, expectations were $0.46. Bruker Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to […]
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.